PIN27 Cost-utility Analysis Focused on Nosocomial Pneumonia Antimicrobial Therapy - Is Ceftolozane/Tazobactam an Option to Fight Antimicrobial Resistance Sustaining Public Health System Affordability in Brazil?
Jun 1, 2021, 00:00 AM
10.1016/j.jval.2021.04.586
https://www.valueinhealthjournal.com/article/S1098-3015(21)00803-2/fulltext
Section Title :
Section Order :
10062
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)00803-2&doi=10.1016/j.jval.2021.04.586